SCHEMBL30689448

SCHEMBL30689448

C=C(Cc1nc(-c2ccc(Oc3nc(C)ns3)cc2)no1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.43
▸ ATM Q13315 1/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ TP53 P04637 3/20 0.42
▸ MITF O75030 1/20 0.42
▸ NCOA3 Q9Y6Q9 1/20 0.42
▸ ACACB O00763 1/20 0.41
▸ FFAR1 O14842 2/20 0.40
▸ GSTP1 P09211 3/20 0.40
▸ MAPT P10636 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689393 0.84 LMNA (0.43) LMNAATMRAB9ATSHRNFKB1
SCHEMBL30689419 0.79 FFAR1 (0.53) LMNAATMRAB9ATSHRNFKB1
SCHEMBL31527955 0.79 LMNA (0.46) LMNAATMRAB9ATSHRNFKB1
SCHEMBL31527908 0.79 FFAR1 (0.42) LMNAATMTSHRTP53MITF
SCHEMBL25802136 0.79 MAPT (0.53) LMNAATMRAB9ATSHRFFAR1
SCHEMBL30689392 0.78 LMNA (0.44) LMNAATMRAB9ATSHRNFKB1
SCHEMBL31527827 0.78 TP53 (0.46) LMNAATMRAB9ATP53MITF
SCHEMBL23578438 0.76 ACACB (0.64) LMNAATMRAB9ATP53MITF
SCHEMBL23578433 0.76 ACACB (0.57) LMNAATMRAB9ATP53MITF
SCHEMBL30689396 0.76 LMNA (0.46) LMNAATMTP53MITFNCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN claimed
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback